Works matching DE "METAL-ammonia compounds"
Results: 81
Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.
- Published in:
- International Journal of Clinical Oncology, 2004, v. 9, n. 2, p. 85, doi. 10.1007/s10147-003-0369-x
- By:
- Publication type:
- Article
The Change of Intracellular pH is Involved in the Cisplatin-Resistance of Human Lung Adenocarcinoma A549/DDP Cells.
- Published in:
- Cancer Investigation, 2005, v. 23, n. 1, p. 26, doi. 10.1081/CNV-46353
- By:
- Publication type:
- Article
Chemotherapy for recurrent or persistent cervical cancer.
- Published in:
- 2004
- By:
- Publication type:
- commentary
Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats.
- Published in:
- Journal of Applied Toxicology, 2004, v. 24, n. 1, p. 27
- By:
- Publication type:
- Article
Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
- Published in:
- International Journal of Urology, 2004, v. 11, n. 6, p. 407, doi. 10.1111/j.1442-2042.2004.00803.x
- By:
- Publication type:
- Article
Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity.
- Published in:
- Human & Experimental Toxicology, 2003, v. 22, n. 10, p. 535, doi. 10.1191/0960327103ht393oa
- By:
- Publication type:
- Article
Comparative Study Between Two Treatment Regimens of Cisplatin-5- Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 2, p. 795
- By:
- Publication type:
- Article
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 391, doi. 10.2147/PPA.S31288
- By:
- Publication type:
- Article
Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release
- Published in:
- Journal of Orthopaedic Research, 2004, v. 22, n. 4, p. 703, doi. 10.1016/j.orthres.2003.10.016
- By:
- Publication type:
- Article
Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1407, doi. 10.3390/ijms18071407
- By:
- Publication type:
- Article
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy.
- Published in:
- Oncology, 1998, v. 55, n. 6, p. 513, doi. 10.1159/000011904
- By:
- Publication type:
- Article
Population Pharmacokinetics of Cycloplatam. II. Clinical Monitoring of the Drug Pharmacokinetics Upon Short and Long-Term Infusion.
- Published in:
- Pharmaceutical Chemistry Journal, 2003, v. 37, n. 11, p. 567, doi. 10.1023/B:PHAC.0000016063.69437.c6
- By:
- Publication type:
- Article
Establishment of Stable hFis1 Knockdown Cells with an siRNA Expression Vector.
- Published in:
- Journal of Biochemistry, 2004, v. 136, n. 4, p. 421, doi. 10.1093/jb/mvh139
- By:
- Publication type:
- Article
Effects of cis-Diamminedichloroplatinum(II) on Escherichia coli and Bacteriophage Systems.
- Published in:
- Journal of Biochemistry, 1998, v. 123, n. 5, p. 821, doi. 10.1093/oxfordjournals.jbchem.a022010
- By:
- Publication type:
- Article
A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 4, p. 915, doi. 10.1038/bjc.2013.432
- By:
- Publication type:
- Article
The effects of MOTILIPERM on cisplatin induced testicular toxicity in Sprague--Dawley rats.
- Published in:
- Cancer Cell International, 2015, v. 15, p. 1, doi. 10.1186/s12935-015-0274-1
- By:
- Publication type:
- Article
Human urothelial carcinoma cell response to Sunitinib malate therapy in vitro.
- Published in:
- Cancer Cell International, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12935-015-0179-z
- By:
- Publication type:
- Article
Thermoanalytical study about histidine and cysteine-cadmium interactions.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2003, v. 74, n. 3, p. 923, doi. 10.1023/B:JTAN.0000011024.89077.43
- By:
- Publication type:
- Article
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6080, doi. 10.1038/sj.onc.1208744
- By:
- Publication type:
- Article
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6090, doi. 10.1038/sj.onc.1208755
- By:
- Publication type:
- Article
Inositol 1,4,5-trisphosphate (IP<sub>3</sub>) receptor type1 (IP<sub>3</sub>R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
- Published in:
- Oncogene, 2005, v. 24, n. 8, p. 1396, doi. 10.1038/sj.onc.1208313
- By:
- Publication type:
- Article
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
- Published in:
- Oncogene, 2005, v. 24, n. 6, p. 970, doi. 10.1038/sj.onc.1208316
- By:
- Publication type:
- Article
p12<sup>CDK2-AP1</sup> mediates DNA damage responses induced by cisplatin.
- Published in:
- Oncogene, 2005, v. 24, n. 3, p. 407, doi. 10.1038/sj.onc.1208222
- By:
- Publication type:
- Article
Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
- Published in:
- Oncogene, 2004, v. 23, n. 42, p. 6997, doi. 10.1038/sj.onc.1207925
- By:
- Publication type:
- Article
Lipoplatin Treatment in Lung and Breast Cancer.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/125192
- By:
- Publication type:
- Article
Thermoelectric Power Generation in a Vacuum Cell of Decomposing Liquid Potassium-Ammonia Solutions.
- Published in:
- Energies (19961073), 2013, v. 6, n. 11, p. 5960, doi. 10.3390/en6115960
- By:
- Publication type:
- Article
Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Magnesium and potassium homeostasis during cisplatin treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 3, p. 231, doi. 10.1007/s00280-004-0899-6
- By:
- Publication type:
- Article
Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-L-cysteine-cDDP by TEA and PAH in the renal proximal tubule.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 2, p. 132, doi. 10.1007/s00280-002-0537-0
- By:
- Publication type:
- Article
Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 5, p. 423, doi. 10.1007/s002800000169
- By:
- Publication type:
- Article
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 255, doi. 10.1007/s002800000167
- By:
- Publication type:
- Article
Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 3, p. 199, doi. 10.1007/s002800050030
- By:
- Publication type:
- Article
P53 Contributes to Cisplatin Induced Renal Oxidative Damage via Regulating P66shc and MnSOD.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2015, v. 37, n. 4, p. 1240, doi. 10.1159/000430247
- By:
- Publication type:
- Article
Magnetic properties of electrons in metal–ammonia solutions.
- Published in:
- Technical Physics, 1997, v. 42, n. 8, p. 855, doi. 10.1134/1.1258747
- By:
- Publication type:
- Article
Inhibition of autophagy enhances cisplatin-induced apoptosis in the MG63 human osteosarcoma cell line.
- Published in:
- Oncology Letters, 2015, v. 10, n. 5, p. 2941, doi. 10.3892/ol.2015.3692
- By:
- Publication type:
- Article
Ethanol Extract of Crataeva nurvala Stem Bark Reverses Cisplatin-induced Nephrotoxicity.
- Published in:
- Pharmaceutical Biology, 2004, v. 42, n. 7, p. 559, doi. 10.1080/13880200490901249
- By:
- Publication type:
- Article
Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.
- Published in:
- Head & Neck, 2014, v. 36, n. 5, p. 617, doi. 10.1002/hed.23339
- By:
- Publication type:
- Article
A Hepatocellular Carcinoma of Massive Arterioportal Shunts Without Tumor Stain Treated with CDDP Two--Route Chemotherapy--A Case Report j.
- Published in:
- Angiology, 1990, v. 41, n. 9, p. 737, doi. 10.1177/000331979004100909
- By:
- Publication type:
- Article
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 97, n. 3, p. 393, doi. 10.1007/s11060-009-0033-z
- By:
- Publication type:
- Article
Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma.
- Published in:
- Diseases of the Esophagus, 2010, v. 23, n. 8, p. 641, doi. 10.1111/j.1442-2050.2010.01070.x
- By:
- Publication type:
- Article
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts.
- Published in:
- Angewandte Chemie International Edition, 2014, v. 53, n. 15, p. 3941, doi. 10.1002/anie.201311161
- By:
- Publication type:
- Article
In vitro release of cisplatin from sol–gel processed organically modified silica xerogels.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2007, v. 18, n. 10, p. 2041, doi. 10.1007/s10856-007-3139-x
- By:
- Publication type:
- Article
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.
- Published in:
- Apoptosis, 2002, v. 7, n. 1, p. 23, doi. 10.1023/A:1013556727182
- By:
- Publication type:
- Article
Chimiothérapie des carcinomes urothéliaux infiltrants de vessie.
- Published in:
- Oncologie (Tech Science Press), 2004, v. 6, n. 4, p. 263, doi. 10.1007/s10269-004-0062-3
- By:
- Publication type:
- Article
Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 315, doi. 10.1159/000209335
- By:
- Publication type:
- Article
Oxytocin alleviates cisplatin-induced renal damage in rats.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2014, v. 17, n. 10, p. 747
- By:
- Publication type:
- Article
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer.
- Published in:
- European Journal of Oral Sciences, 1997, v. 105, n. 5p2, p. 523, doi. 10.1111/j.1600-0722.1997.tb00239.x
- By:
- Publication type:
- Article
Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats.
- Published in:
- Kidney International, 1985, v. 28, n. 6, p. 914, doi. 10.1038/ki.1985.217
- By:
- Publication type:
- Article
The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice.
- Published in:
- Laboratory Animals, 2006, v. 40, n. 3, p. 296
- By:
- Publication type:
- Article